Sugi Predict

Sugi Predict / Compounds / SCHEMBL2954430

SCHEMBL2954430

SCHEMBL2954430

CC[N+](C)(C)c1ccccc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ACHE P22303 3/20 0.56
▸ TSHR P16473 1/20 0.56
▸ OPRM1 P35372 1/20 0.56
▸ SMN1; SMN2 Q16637 2/20 0.54
▸ BLM P54132 1/20 0.54
▸ APOBEC3A P31941 1/20 0.50
▸ APOBEC3G Q9HC16 1/20 0.50
▸ TP53 P04637 2/20 0.39
▸ KDM4E B2RXH2 1/20 0.39
▸ ALDH1A1 P00352 1/20 0.39
▸ TDP1 Q9NUW8 1/20 0.39
▸ CHRNB2 P17787 2/20 0.35
▸ CHRNB4 P30926 2/20 0.35
▸ CHRNA3 P32297 2/20 0.35
▸ CHRNA7 P36544 2/20 0.35
▸ CHRNA4 P43681 2/20 0.35
▸ NPSR1 Q6W5P4 1/20 0.34
▸ DNM1 Q05193 2/20 0.33
▸ PSIP1 O75475 1/20 0.33
▸ MEN1 O00255 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7553902 0.97 ACHE (0.54) ACHETSHROPRM1SMN1; SMN2BLM
SCHEMBL7553904 0.97 ACHE (0.54) ACHETSHROPRM1SMN1; SMN2BLM
Bromide SCHEMBL3881994 0.97 ACHE (0.57) ACHETSHROPRM1SMN1; SMN2BLM
Hydrochloric Acid SCHEMBL11288802 0.97 ACHE (0.57) ACHETSHROPRM1SMN1; SMN2BLM
Fluoride Ion SCHEMBL7548962 0.97 ACHE (0.54) ACHETSHROPRM1SMN1; SMN2BLM
Water SCHEMBL7548761 0.97 ACHE (0.54) ACHETSHROPRM1SMN1; SMN2BLM
Bromide SCHEMBL2575147 0.95 ACHE (0.55) ACHETSHROPRM1SMN1; SMN2BLM
Bromide SCHEMBL2575151 0.95 ACHE (0.55) ACHETSHROPRM1SMN1; SMN2BLM
SCHEMBL11569379 0.93 ACHE (0.50) ACHETSHROPRM1SMN1; SMN2BLM
Bromide SCHEMBL2575150 0.91 ACHE (0.52) ACHETSHROPRM1SMN1; SMN2BLM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 73 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240174523-A1 SYNTHESIS OF ZEOLITIC MATERIAL HAVING AFT FRAMEWORK STRUCTURE AND SCR CATALYSTS COMPRISING THE SAME BASF CORPORATION 2024-05-30 — — US claimed
EP-4313864-A1 SYNTHESIS OF ZEOLITIC MATERIALS HAVING AFT FRAMEWORK STRUCTURE AND SCR CATALYSTS COMPRISING THE SAME BASF Corporation (US) 2024-02-07 — — EP claimed
CN-117062777-A Synthesis of zeolite material having AFT framework structure and SCR catalyst comprising the same 巴斯夫公司 2023-11-14 — — CN claimed
WO-2022199574-A1 SYNTHESIS OF ZEOLITIC MATERIALS HAVING AFT FRAMEWORK STRUCTURE AND SCR CATALYSTS COMPRISING THE SAME BASF CORPORATION (US) 2022-09-29 — — WO claimed
CN-108148394-B Storage-stable one-component polyurethane prepregs from polyurethane compositions and moldings produced therefrom 赢创运营有限公司 2021-12-28 — — CN claimed
US-11149356-B2 Methods of forming metals using ionic liquids BATTELLE ENERGY ALLIANCE, LLC (US) 2021-10-19 — — US claimed
US-20190186031-A1 METHODS OF FORMING METALS USING IONIC LIQUIDS UNITED STATES DEPARTMENT OF ENERGY 2019-06-20 — — US claimed
CN-109772443-A A kind of molecular sieve carried high dispersive Pt catalyst of ZSM-12 and preparation method thereof 中触媒新材料股份有限公司 2019-05-21 — — CN claimed
EP-2663335-A1 A COMPOSITION FOR THE REGENERATION OF ATROPHIC TISSUES Medestea Internazionale S.p.A. (IT) 2013-11-20 — — EP claimed
US-20130287757-A1 COMPOSITION FOR THE REGENERATION OF ATROPHIC TISSUES MEDESTEA INTERNAZIONALE S.P.A. (IT) 2013-10-31 — — US claimed
WO-2012095702-A1 A COMPOSITION FOR THE REGENERATION OF ATROPHIC TISSUES MEDESTEA INTERNAZIONALE S.P.A. (IT) 2012-07-19 — — WO claimed
CN-101115562-A Packing material for ion chromatography SHOWA DENKO KK (JP) 2008-01-30 — — CN claimed
US-4292417-A CROSSLINKED SULFATED POLYETHER DAICEL LTD. (JP) 1981-09-29 — — US claimed
US-4200726-A Semipermeable membrane of phenoxy resin containing sulfuric acid groups or salts thereof DAICEL LTD. (JP) 1980-04-29 — — US claimed
US-20240174523-A1 SYNTHESIS OF ZEOLITIC MATERIAL HAVING AFT FRAMEWORK STRUCTURE AND SCR CATALYSTS COMPRISING THE SAME BASF CORPORATION 2024-05-30 — — US disclosed
EP-4313864-A1 SYNTHESIS OF ZEOLITIC MATERIALS HAVING AFT FRAMEWORK STRUCTURE AND SCR CATALYSTS COMPRISING THE SAME BASF Corporation (US) 2024-02-07 — — EP disclosed
CN-117062777-A Synthesis of zeolite material having AFT framework structure and SCR catalyst comprising the same 巴斯夫公司 2023-11-14 — — CN disclosed
EP-0273531-A1 1-Methyl-1h-imidazole-5-carboxylic acid derivatives JANSSEN PHARMACEUTICA N.V. (BE) 1988-07-06 — — EP disclosed
US-4292417-A CROSSLINKED SULFATED POLYETHER DAICEL LTD. (JP) 1981-09-29 — — US disclosed
US-4200726-A Semipermeable membrane of phenoxy resin containing sulfuric acid groups or salts thereof DAICEL LTD. (JP) 1980-04-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130287757-A1 COMPOSITION FOR THE REGENERATION OF ATROPHIC TISSUES CUTA, UNG, MMP1 ACHE 27/4885TSHR 2748/4885OPRM1 4110/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.